WO2009151302A3 - 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물 - Google Patents

산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물 Download PDF

Info

Publication number
WO2009151302A3
WO2009151302A3 PCT/KR2009/003176 KR2009003176W WO2009151302A3 WO 2009151302 A3 WO2009151302 A3 WO 2009151302A3 KR 2009003176 W KR2009003176 W KR 2009003176W WO 2009151302 A3 WO2009151302 A3 WO 2009151302A3
Authority
WO
WIPO (PCT)
Prior art keywords
ginseng
aging
cell lines
stem cell
composition
Prior art date
Application number
PCT/KR2009/003176
Other languages
English (en)
French (fr)
Other versions
WO2009151302A9 (ko
WO2009151302A2 (ko
Inventor
장미옥
임민정
오일석
이대희
이은경
진영우
Original Assignee
주식회사 운화바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP09762688A priority Critical patent/EP2308462A2/en
Priority to RU2011100824/15A priority patent/RU2500386C2/ru
Priority to AU2009258386A priority patent/AU2009258386B2/en
Priority to US12/997,858 priority patent/US20110097310A1/en
Priority to CA2732058A priority patent/CA2732058C/en
Priority to BRPI0909876-3A priority patent/BRPI0909876A2/pt
Application filed by 주식회사 운화바이오텍 filed Critical 주식회사 운화바이오텍
Priority to CN200980130417.7A priority patent/CN102159182B/zh
Priority to JP2011513433A priority patent/JP5572786B2/ja
Publication of WO2009151302A2 publication Critical patent/WO2009151302A2/ko
Publication of WO2009151302A3 publication Critical patent/WO2009151302A3/ko
Publication of WO2009151302A9 publication Critical patent/WO2009151302A9/ko
Priority to US13/863,817 priority patent/US9095532B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 산삼 또는 인삼을 포함하는 인삼류(Panax ginseng)의 형성층 유래 세포주, 그 파쇄물, 그 추출물 및 그 배양물 중 어느 하나 이상을 유효성분으로 함유하는 노화 방지 또는 항산화용 조성물에 관한 것이다. 본 발명에 따른 조성물은 본 발명에 따른 세포주, 그 파쇄물, 그 추출물 및 그 배양물은 기존 항노화제와 항산화제의 부작용을 최소화하여 피부에 안전하면서도, 피부노화의 주요 원인인 자외선 노출에 의한 활성산소를 억제하는 항산화 작용을 나타내며, 노화와 관련된 인자들을 효과적으로 감소 또는 억제할 수 있으므로, 노화 예방 및 억제에 유용하다.
PCT/KR2009/003176 2008-06-13 2009-06-12 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물 WO2009151302A2 (ko)

Priority Applications (9)

Application Number Priority Date Filing Date Title
RU2011100824/15A RU2500386C2 (ru) 2008-06-13 2009-06-12 ПРОТИВОВОЗРАСТНАЯ ИЛИ АНТИОКСИДАНТНАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ЛИНИЮ РАСТИТЕЛЬНЫХ СТВОЛОВЫХ КЛЕТОК, ПОЛУЧЕННЫХ ИЗ КАМБИЯ Panax ginseng, ВКЛЮЧАЯ ЖЕНЬШЕНЬ ДИКОГО ТИПА И ЖЕНЬШЕНЬ КОРЕЙСКИЙ
AU2009258386A AU2009258386B2 (en) 2008-06-13 2009-06-12 Composition for anti-aging or antioxidation containing plant stem cell lines derived from cambium of Panax Ginseng including wild ginseng and ginseng as active components
US12/997,858 US20110097310A1 (en) 2008-06-13 2009-06-12 Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng
CA2732058A CA2732058C (en) 2008-06-13 2009-06-12 Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng
BRPI0909876-3A BRPI0909876A2 (pt) 2008-06-13 2009-06-12 composição, cosmético e alimento funcional anti-envelhecimento ou antioxidante contendo linhagem de células de caule vegetal derivada de câmbio de panax ginseng
EP09762688A EP2308462A2 (en) 2008-06-13 2009-06-12 Composition for anti-aging or antioxidation containing plant stem cell lines derived from cambium of panax ginseng including wild ginseng and ginseng as active components
CN200980130417.7A CN102159182B (zh) 2008-06-13 2009-06-12 含有源于人参，包括野山参及高丽参的形成层的植物干细胞系作为活性成分的抗衰老或抗氧化组合物
JP2011513433A JP5572786B2 (ja) 2008-06-13 2009-06-12 天然高麗人参または高麗人参を含む高麗人参類の形成層由来植物幹細胞株を有効成分として含有する老化防止または抗酸化用組成物
US13/863,817 US9095532B2 (en) 2008-06-13 2013-04-16 Composition for anti-aging or antioxidant composition containing plant stem cell line derived from cambium or Panax ginseng including wild ginseng and ginseng as active components

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0056008 2008-06-13
KR20080056008 2008-06-13

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/997,858 A-371-Of-International US20110097310A1 (en) 2008-06-13 2009-06-12 Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng
US13/863,817 Continuation US9095532B2 (en) 2008-06-13 2013-04-16 Composition for anti-aging or antioxidant composition containing plant stem cell line derived from cambium or Panax ginseng including wild ginseng and ginseng as active components

Publications (3)

Publication Number Publication Date
WO2009151302A2 WO2009151302A2 (ko) 2009-12-17
WO2009151302A3 true WO2009151302A3 (ko) 2010-03-11
WO2009151302A9 WO2009151302A9 (ko) 2010-06-10

Family

ID=41417270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/003176 WO2009151302A2 (ko) 2008-06-13 2009-06-12 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물

Country Status (10)

Country Link
US (2) US20110097310A1 (ko)
EP (1) EP2308462A2 (ko)
JP (1) JP5572786B2 (ko)
KR (1) KR101126315B1 (ko)
CN (1) CN102159182B (ko)
AU (1) AU2009258386B2 (ko)
BR (1) BRPI0909876A2 (ko)
CA (1) CA2732058C (ko)
RU (1) RU2500386C2 (ko)
WO (1) WO2009151302A2 (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951863B1 (en) 2005-10-31 2015-07-08 Unhwa Corporation Stability of secondary metabolite mass production through syncronized plant cell cultures
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
KR101064518B1 (ko) * 2007-09-21 2011-09-19 주식회사 운화 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법
WO2009151302A2 (ko) 2008-06-13 2009-12-17 주식회사 운화바이오텍 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물
KR101179171B1 (ko) 2008-08-14 2012-09-03 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
EP2363137A4 (en) 2008-09-30 2012-08-01 Unhwa Corp COMPOSITION FOR THE PREVENTION OR TREATMENT OF AIDS WITH PLANT GINSENG VEGETABLE GAMBLING LINE FROM THE BAMBIUM OF PANAX GINSENG OR GINSENG AS AN ACTIVE SUBSTANCE
KR101141166B1 (ko) * 2009-05-26 2012-05-02 주식회사 운화 은행나무과의 형성층 유래 식물줄기세포 및 이의 분리방법
KR101233991B1 (ko) * 2010-03-18 2013-02-18 동국대학교 산학협력단 발효홍삼의 제조방법
KR101233987B1 (ko) * 2010-03-18 2013-02-18 동국대학교 산학협력단 발효홍삼의 제조방법
CN103841956B (zh) * 2011-03-27 2016-11-09 奥麒化工有限公司 调节表观遗传dna甲基化以导致细胞采取与年轻细胞相关的dna甲基化模式
KR101321011B1 (ko) * 2011-11-30 2013-10-23 주식회사 엘지생활건강 피부결 개선용 조성물
WO2013102882A2 (en) 2012-01-05 2013-07-11 L'oreal Cosmetic use of dedifferentiated plant cells
FR3007982B1 (fr) 2013-07-05 2015-08-21 Oreal Stabilisation des cellules dedifferenciees de rose.
JP6483240B2 (ja) * 2014-08-22 2019-03-13 ウェルキー ホールディングス リミテッドＷｅｌｌｋｅｙ Ｈｏｌｄｉｎｇｓ Ｌｉｍｉｔｅｄ 希少ジンセノサイドを高含量で含有する、山参もしくは高麗人参を含む高麗人参類の抽出物または高麗人参類の形成層由来植物幹細胞もしくはその抽出物の製造方法
CN104498425B (zh) * 2014-11-28 2016-03-02 广州赛莱拉干细胞科技股份有限公司 雪莲干细胞的分离培养方法及在制备抗衰老产品中的应用
KR101836354B1 (ko) * 2015-03-09 2018-03-09 주식회사 한국화장품제조 산삼배양근 오일을 유효성분으로 포함하는 화장료 조성물
EP3135341B1 (en) 2015-08-27 2019-02-20 Latvijas Universitate Cosmetic skin whitening compositions containing extracts derived from in vitro propagated hypericum hirsutum
CN105748343B (zh) * 2016-02-25 2018-06-15 广州市科玮生物技术有限公司 一种天然植物提取物组合物及其在化妆品中的应用
CN105661240A (zh) * 2016-03-10 2016-06-15 浙江博士园生物技术有限公司 一种北虫草饮料及其制备方法
CN105919886A (zh) * 2016-06-13 2016-09-07 广东万海细胞生物科技有限公司 一种速效修复皱纹的乳液及其制备方法
CN105963211A (zh) * 2016-07-02 2016-09-28 广东万海细胞生物科技有限公司 一种深层护理面膜膏及其制备方法
KR101759650B1 (ko) * 2017-04-03 2017-07-19 연세대학교 산학협력단 오시멘(Ocimene) 또는 이의 염을 유효성분으로 함유하는 피부주름 개선, 보습, 탄력증진, 각질제거, 홍반억제 또는 피부광노화 개선용 조성물
CN107616964A (zh) * 2017-09-15 2018-01-23 广州赛莱拉干细胞科技股份有限公司 一种高丽参干细胞护肤组合物及其制备方法
CN107789306A (zh) * 2017-10-31 2018-03-13 广州赛莱拉干细胞科技股份有限公司 一种高丽参干细胞提取物滋润保湿护肤组合物及其制备方法
KR102655941B1 (ko) * 2018-08-13 2024-04-11 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 항산화 조성물
KR102394647B1 (ko) * 2018-08-29 2022-05-09 (주)아모레퍼시픽 인삼 세포 파쇄물을 포함하는 피부 탄력 증진용 또는 피부 주름 개선용 조성물
KR102187618B1 (ko) * 2018-11-01 2020-12-07 (주)아모레퍼시픽 수크로스, 인돌-3-아세트산 및 로즈힙 열매 추출물의 혼합물을 포함하는 피부 외용제 조성물
JP2020200298A (ja) * 2019-06-13 2020-12-17 株式会社再春館製薬所 皮膚外用剤
FR3105259B1 (fr) 2019-12-19 2022-03-11 Oreal Cellules végétales dédifférenciées non élicitées deLavandula angustifolia, ses extraits et ses utilisations cosmétiques
KR20210156482A (ko) * 2020-06-18 2021-12-27 성균관대학교산학협력단 라이소인지질 함유 수용성 안정화 조성물 및 이의 제조 방법
CN114053204A (zh) * 2021-11-01 2022-02-18 上海普瑞康企业发展有限公司 一种含长白山野山参细胞水提取物的抗衰霜
CN117362110B (zh) * 2023-11-02 2024-02-13 烟台众德集团有限公司 一种基于壳寡糖的缓释肥料及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990057560A (ko) * 1997-12-30 1999-07-15 박명규 인삼의 부위별 유해산소제거효소 함량증가 효과 검증방법 및 항 산화 효능을 갖는 인삼 엑스
KR20020055483A (ko) * 2000-12-28 2002-07-09 서경배 인삼 어글리콘을 함유하는 피부 노화방지용 화장료 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61173774A (ja) * 1985-01-26 1986-08-05 Nissho Kisetsu:Kk 生薬成分を含む生物組織の培養法
JPS6239529A (ja) * 1985-08-13 1987-02-20 Nitto Electric Ind Co Ltd 薬用人参エキスの製造方法
FR2647342B1 (fr) * 1989-05-23 1994-05-27 Sanofi Sa Composition cosmetique s'opposant au vieillissement de la peau
DE4028622C2 (de) * 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen
JPH10182412A (ja) * 1996-12-27 1998-07-07 Kose Corp 外用剤
KR100253842B1 (ko) 1997-09-12 2000-07-01 유상옥 멀베린을 함유하는 미백화장료
KR100361433B1 (ko) 1998-05-28 2003-01-24 주식회사 태평양 인삼추출물을함유하는피부노화방지용화장료조성물
KR100295875B1 (ko) 1998-11-07 2001-11-14 정찬복 초두구추출물을함유하는화장료
KR20030009454A (ko) * 2000-05-31 2003-01-29 카가쿠키쥬쯔 신코지교단 진세노사이드Ｒｂ1으로 된 피부조직 재생촉진제
KR100440193B1 (ko) 2001-01-08 2004-07-12 김기창 탄성밴드 제조방법 및 그 탄성밴드
KR100479803B1 (ko) * 2002-04-08 2005-03-30 홍림통산(주) 약효가 증가된 특수가공처리 인삼 추출물을 함유하는뇌졸증의 예방 및 치료를 위한 조성물
KR100533120B1 (ko) 2003-06-16 2005-12-14 주식회사 운화 바이오텍 형성층을 이용한 식물세포배양 방법
EP1951863B1 (en) * 2005-10-31 2015-07-08 Unhwa Corporation Stability of secondary metabolite mass production through syncronized plant cell cultures
WO2009151302A2 (ko) 2008-06-13 2009-12-17 주식회사 운화바이오텍 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990057560A (ko) * 1997-12-30 1999-07-15 박명규 인삼의 부위별 유해산소제거효소 함량증가 효과 검증방법 및 항 산화 효능을 갖는 인삼 엑스
KR20020055483A (ko) * 2000-12-28 2002-07-09 서경배 인삼 어글리콘을 함유하는 피부 노화방지용 화장료 조성물

Also Published As

Publication number Publication date
CA2732058C (en) 2014-09-23
KR20090129963A (ko) 2009-12-17
JP2011522884A (ja) 2011-08-04
CN102159182B (zh) 2014-09-03
WO2009151302A9 (ko) 2010-06-10
KR101126315B1 (ko) 2012-03-23
RU2011100824A (ru) 2012-08-10
RU2500386C2 (ru) 2013-12-10
US9095532B2 (en) 2015-08-04
EP2308462A2 (en) 2011-04-13
CA2732058A1 (en) 2009-12-17
AU2009258386B2 (en) 2013-04-04
AU2009258386A1 (en) 2009-12-17
US20130302287A1 (en) 2013-11-14
CN102159182A (zh) 2011-08-17
BRPI0909876A2 (pt) 2020-09-01
US20110097310A1 (en) 2011-04-28
JP5572786B2 (ja) 2014-08-20
WO2009151302A2 (ko) 2009-12-17

Similar Documents

Publication Publication Date Title
WO2009151302A3 (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물
WO2007131677A8 (en) Use of ginsenosides and extracts containing them
ZA201701460B (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles
EP2353603A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER CONTAINING AS ACTIVE INGREDIENT A CELL LINE OF VEGETABLE STEM CELLS EXTRACTED FROM PANAX GINSENG INCLUDING WILD GINSENG OR GINSENG
NZ742943A (en) Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex i or ii
WO2009139581A3 (ko) 주목의 형성층 또는 전형성층 유래 식물줄기세포주를 유효성분으로 함유하는 항산화, 항염증 또는 항노화용 조성물
MX342293B (es) Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.
WO2013027984A3 (ko) 녹차 성분을 함유하는 화장료 조성물
DK1768500T3 (da) Sammensætninger egnet til behandling af kutane tegn på aldring
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
WO2012157978A3 (ko) 팥꽃나무 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 아토피 예방 또는 치료용 약학적 조성물
MX340484B (es) Metodo para reducir daños por quemaduras de sol en las plantas.
WO2010020424A3 (de) Verwendung von glucosylglycerol
EP2399596A4 (en) Immune enhancing composition which contains a plant stem cell line derived from cambium panax ginseng with wild ginseng or ginseng as the active ingredient
WO2011051633A3 (fr) Utilisation d'un extrait de punica granatum pour lutter contre la canitie
WO2011014025A3 (ko) 펩타이드가 결합된 하이드록시 시나믹산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
WO2011065719A3 (ko) 홍삼 다당체 추출물을 함유하는 피부 외용제 조성물
EP2335712A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER DISEASES CONTAINING VEGETABLE STEM CELL LINES DERIVED FROM PANAX GINSENG CAMBIUM COMPRISING MOUNTAIN GINSENG OR GINSENG AS ACTIVE INGREDIENT
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
WO2009090394A3 (en) Composition containing capsicum for treating a skin disorder
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
EP2363137A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF AIDS WITH PLANT GINSENG VEGETABLE GAMBLING LINE FROM THE BAMBIUM OF PANAX GINSENG OR GINSENG AS AN ACTIVE SUBSTANCE
AU2014214625A8 (en) Bioactive compositions from Theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like
WO2014090526A3 (de) Wirkstoffkombination zur hautaufhellung i
WO2009137900A3 (en) Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980130417.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09762688

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2732058

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2011513433

Country of ref document: JP

Ref document number: 4741/KOLNP/2010

Country of ref document: IN

Ref document number: 2009762688

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009258386

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12997858

Country of ref document: US

Ref document number: 2011100824

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2009258386

Country of ref document: AU

Date of ref document: 20090612

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: PI0909876

Country of ref document: BR

Free format text: APRESENTAR, EM ATE 60 (SESSENTA) DIAS, DOCUMENTOS COMPROBATORIOS QUE EXPLIQUEM E REGULARIZEM A DIVERGENCIA NO NOME DO DEPOSITANTE NA PUBLICACAO INTERNACIONAL WO/2009/151302 DE 17/12/2009 COMO UNHWA BIOTECH. CORP. E O CONSTANTE NAS PETICOES NO 018100047266 DE 13/12/2010, NO 018110004536 DE 09/02/2011 E NO 018120020899 DE 12/06/2012 COMO UNHWA CORPORATIONESTA EXIGENCIA DEVERA SER RESPONDIDA COM GRU DE CODIGO 207 E EM NOME DO DEPOSITANTE ORIGINAL DO PEDIDO, VISTO QUE NAO HOUVE JULGAMENTO AINDA DA PETICAO SOLICITANDO A TRANSFERENCIA DE TITULARIDADE.

ENP Entry into the national phase

Ref document number: PI0909876

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20101213